Radiation recall dermatitis in a patient affected with pheochromocytoma after treatment with lanreotide.
Bauzá
A
A
Del Pozo
L J
LJ
Escalas
J
J
Mestre
F
F
D000310:Adrenal Gland Neoplasms / Q000473:pathology; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000532:radiotherapy / Q000556:secondary; D003875:Drug Eruptions / Q000209:etiology; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D010456:Peptides, Cyclic / Q000009:adverse effects*; D010673:Pheochromocytoma / Q000556:secondary / Q000628:therapy; D011855:Radiodermatitis / Q000139:chemically induced*; D013004:Somatostatin / Q000009:adverse effects / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin